about
Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinCharged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteinsTopological changes in the transmembrane domains of hepatitis C virus envelope glycoproteinsSubcellular Localization and Topology of the p7 Polypeptide of Hepatitis C VirusRecognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus EntryCD81-Dependent Binding of Hepatitis C Virus E1E2 HeterodimersThe association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entryThe transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerizationGlycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell lineThe Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infectionInteracting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infectionClaudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Hepatitis C virus entry: potential receptors and their biological functions.Early steps of the hepatitis C virus life cycle.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusCD81 and hepatitis C virus (HCV) infection.Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex.EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.The antimalarial ferroquine is an inhibitor of hepatitis C virus.Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.Characterization of functional hepatitis C virus envelope glycoproteins.Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval.SRFBP1, an Additional Player in HCV Entry.Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions.Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop.HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses.Hepatocyte-derived cultured cells with unusual cytoplasmic keratin-rich spheroid bodies.Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.Hepatitis C virus entry into the hepatocyteInvestigation of the role of GBF1 in the replication of positive-sense single-stranded RNA virusesNew insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle[Occludin, an additional key for hepatitis C virus entry]Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis
P50
Q24598370-0F319694-9804-4B6B-A348-89E8B487AC5FQ27333881-272F683D-66ED-40D7-9887-982D07101291Q27469653-87D07334-2C3F-4C52-AF96-DC274809E136Q27472616-376B02A0-0EE7-425A-B9D2-01CD1D061BBDQ27472868-FE3E6B61-38C2-4CE2-9397-9789BEF6D55CQ27473084-3B6BEE2B-A783-4291-BA8A-6B06FDBCB485Q27485588-2DB5782C-3B6E-4A87-8592-4D585A99AAB3Q27485659-E1D1119C-D7BA-4B75-8969-22935EC87F76Q27488727-7384F3E4-0F87-40F6-A37E-80DF8F56B2E5Q27622511-8F4A713E-F93D-4EA9-A26B-C0E4499F31B4Q28206033-5F47037E-412A-4290-8CE3-1C67136AC668Q33553648-CC859BD2-EDDE-4D14-8F2B-A20365C3617DQ34799950-9885FB34-C915-4AB4-810A-4D1DA73FF58CQ35839680-BC0EAD39-EDAC-47D0-BF19-31CA2BF7E433Q35914270-D3C337CA-7FE6-40A4-ABF7-9206A37042E0Q36444205-5F1C1341-7442-4443-A232-36266FF118BAQ37032802-B7F6ABD3-0A91-4AC5-ACBA-A69B99A023ADQ37252935-5DB6DC30-B6A9-4677-8FE2-9952B47D8CBFQ37611819-9C92C7B7-6C9E-47C2-8D26-CA24A518507AQ38325724-48E30EEC-DEA2-44BB-A31A-3B10240BB7FCQ39204571-31781458-ECB6-4841-A9AA-302A28BF3EF5Q39205134-1EA74AFD-2CD1-4BB0-ADF2-D70CC9D0F9ADQ40057653-8F9C8A8B-675F-4767-928B-5A0233B9FF24Q40094231-5E1FB5C3-715A-44E9-AB8B-AE82C50567DAQ40539381-6D9C04DC-DA3C-446C-B569-866CCC3B3151Q40744404-E87A53E9-5574-4133-A6F2-AC300554E940Q40993767-50CB29F3-9073-476D-8561-8486A4F2A7E0Q41026541-8E64BFD5-A52A-4425-A77A-9FC82167C661Q41928416-D736CD2D-A001-4107-ADC6-523BC0652827Q42986278-D709D60D-5F6C-461C-A422-343DFC435826Q42990660-C366F424-2A44-4828-B466-2909EBA67D8CQ42992931-D6D4C5C4-9213-4A9F-A9B6-5D1B34375E6EQ45094515-DFA5354C-AC5B-482B-A01C-0D9FA114549AQ45325189-3265767D-12BD-4887-BCB9-6705A9D19C9DQ52371420-C0F5CD65-C8E5-416C-883D-27EE79F4C150Q56911131-4F5B0EF4-7129-442C-95C7-76766E3E3C23Q56926504-17A69B9D-D568-43F0-AD7A-1F3E6472391EQ64104079-4AE278FF-7672-41EF-94FC-0BF5ED0B4BB9Q84229492-07E15D9C-117C-4D0D-B413-B922F714B77CQ90004257-5B319F3A-68B8-4023-BF0E-786117F3F09B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
L Cocquerel
@ast
L Cocquerel
@en
L Cocquerel
@es
L Cocquerel
@nl
L Cocquerel
@sl
type
label
L Cocquerel
@ast
L Cocquerel
@en
L Cocquerel
@es
L Cocquerel
@nl
L Cocquerel
@sl
prefLabel
L Cocquerel
@ast
L Cocquerel
@en
L Cocquerel
@es
L Cocquerel
@nl
L Cocquerel
@sl
P214
P106
P214
P31
P496
0000-0002-2136-5178
P7859
viaf-197204283